Each capsule contains the following: Pinene [α + β] 31.0 mg Camphene 15.0 mg Cineol 3.0 mg Fenchone 4.0 mg Borneol 10.0 mg Anethol 4.0 mg
Indications And Usage:
Urolithiasis, nephrolithiasis and mild urinary tract infections. Rowatinex® promotes the disintegration of stones, and by its spasmolytic action promotes the spontaneous passage of stones in the renal and urinary tracts. Rowatinex® gives symptomatic relief of mild to moderate renal and urinary colic associated with the presence of stones in the renal and urinary tracts. Rowatinex® is also indicated for the relief of frequency and urgency associated with mild urinary tract infections.
None known. Special warnings and precautions for use Rowatinex® is not suitable for use in patients with severe colic, anuria or severe infection of the urinary tract.
An insignificant number of patients reported slight and transient gastric disturbance.
Dosage & Administration:
Route of Administration: Oral. Adults: One capsule 3 or 4 times daily before meals. No dose recommendation for children.
Rowatinex® should not be used in patients receiving oral anti-coagulants or other drugs metabolised by the liver where dose is critical.
Strips of 45 capsules in packs of 3 strips.
Pregnancy & Lactation:
Although no teratogenic effects have been reported, Rowatinex® should not be given in the first trimester of pregnancy. Although no evidence is available, Rowatinex® should not be given to lactating females.